{"abstract":null,"action":"Notice of application.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/07/08/2020-14614.html","cfr_references":[],"citation":"85 FR 41065","comment_url":null,"comments_close_on":"2020-08-07","correction_of":null,"corrections":[],"dates":"Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 7, 2020. Such persons may also file a written request for a hearing on the application on or before August 7, 2020.","disposition_notes":null,"docket_ids":["Docket No. DEA-679"],"dockets":[],"document_number":"2020-14614","effective_on":null,"end_page":41065,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/07/08/2020-14614.xml","html_url":"https://www.federalregister.gov/documents/2020/07/08/2020-14614/importer-of-controlled-substances-application-galephar-pharmaceutical-research-inc","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-14614?publication_date=2020-07-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-07-08/2020-14614/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":73,"last_updated":"2026-04-05 00:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-07-08/pdf/2020-14614.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-14614.pdf?1594125921","publication_date":"2020-07-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/07/08/2020-14614.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T03:54:46Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":41065,"subtype":null,"title":"Importer of Controlled Substances Application: Galephar Pharmaceutical Research, Inc.","toc_doc":"Galephar Pharmaceutical Research, Inc.","toc_subject":"Importers of Controlled Substances; Applications:\n","topics":[],"type":"Notice","volume":85}